At PredictCan Biotechnologies we utilize patients’ clinical and pathological data to reprogram cells in a 3D system offering a unique perspective for clinical trial in the dish and personalized therapy.
Diagnostic Area
At PredictCan Biotechnologies we combine cell reprogramming technology with artificial intelligence to detect precancerous signals for early diagnosis and metastasis.
0
March 2022
PredictCan Biotechnologies has been awarded by Bpifrance and received a “Bourse French Tech Emergence”
